LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW)

CUSIP: 55068A118

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
5,041,166
Share change
+232,050
Total reported value
$2,111,980
Price per share
$0.42
Number of holders
29
Value change
-$434,744
Number of buys
8
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 55068A118?
CUSIP 55068A118 identifies LUXAW - LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) as of Q1 2022

As of 31 Mar 2022, LUX HEALTH TECH ACQUISITION - *W EXP 11/30/202 (LUXAW) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,041,166 shares. The largest 10 holders included COWEN AND COMPANY, LLC, Wolfswood Holdings, LLC, Empyrean Capital Partners, LP, Balyasny Asset Management LLC, MYDA Advisors LLC, Sage Rock Capital Management LP, Castle Creek Arbitrage, LLC, AQR Arbitrage LLC, BBR PARTNERS, LLC, and Jefferies Group LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.